Rocket Lab Corporation RKLB
Composite 42/100; the shares have moved about 103% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 11/100 — a strong mark against it.
Growth ranks 92/100 — a strong point in its favour. Balance-sheet strength ranks 64/100 — a moderate point in its favour.
Valuation ranks 11/100 — a strong mark against it. Quality ranks 19/100 — a strong mark against it. Momentum ranks 42/100 — a slight mark against it.
What the company does Rocket Lab designs and manufactures small-to-medium orbital rockets (Electron, Neutron) and spacecraft components, serving commercial, government, and aerospace prime customers globally.
Key financials RKLB posts negative profitability: ROE -13.6%, ROA -6.6%, ROCE -8.4%; gross margin 36.6% but operating margin -22.4% and net margin -26.9%. Revenue grew 63.5% while EPS growth was 0.0%. Debt/Equity is 0.06 and current ratio 4.47.
Stock health Sidera scores RKLB “Poor quality, fairly valued” (Overall 48.1/100), with Quality 16.3 and Valuation 60.8. Price momentum is mixed: -21.42% over 3m, -24.33% over 6m, +39.61% over 12m, and -57.06% below its 52-week high.
Price vs fair value The stock trades at a PREMIUM of 76.56% versus the 12-month analyst target of 114.47. - Analysts see 76.56% upside to the 114.47 target (analyst count 15.0). - Recent contract wins totaling $981M from Space Force were highlighted by Investor’s Business Daily and Stocktwits. - 24/7 Wall St. cited three catalysts driving the stock higher. - Simply Wall St. noted three additional iQPS launches, bringing planned missions to 18.
Looking forward Neutron development and responsive-space initiatives could support long-term growth, but sustained negative margins and high valuation percentiles warrant caution until profitability improves.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.